Subscribe

RSS Feed (xml)

Powered By

Skin Design:
Free Blogger Skins

Powered by Blogger

Showing posts with label Biochemistry and Molecular Biology. Show all posts
Showing posts with label Biochemistry and Molecular Biology. Show all posts

Thursday, April 10, 2008

article : Cloning Process

Cloning - Cells derived from a single cell through mitosis constitute a clone and the process of obtaining clones is called cloning. (Asexual progeny of a single individual make up a clone).

In simple terms, cloning consists of trypsinisation of a monolayer culture to prepare a cell suspension, 3-4 dilution steps to achieve a suitable cell density (10-200 cells/ml), and seeding in Petri dishes or flasks or multi well dishes. The culture vessels are incubated for 1-3 weeks with a medium change after 1 week; by this time colonies will develop.

Colonies may be isolated

(1) directly from multi well dishes by trypsinisation of usually such wells, which contained only one cell at the start, or which have a single distinct colony originating from a single cell lying away from other nondividing cell or cells. This is confirmed by microscopic observation.

(2) Isolation of clones from petriplates is done by using cloning rings, which are placed around the desired colonies after the medium is poured. The cell colony within each porcelain, teflon or stainless steel ring is trypisnized, cells are suspended in medium and seeded in a well of multiwell plate or in a flask. Alternatively,

(3) the desired colony may be shielded and the remaining colonies are irradiated by a lethal dose (3,000 rads) of X-rays or gamma-rays. The protected colony is trypsinised, and the cells are cloned in the same plate; the irradiated cells serve as a feeder layer.

Plating efficiency (per cent of cells forming colonies) of continuous cell lines is generally 10% or higher, while that of finite cell lines may be quite low, say, 0.5-5% or even zero.

Several approaches have been used to enhance the plating efficiency, e.g.,

(i) use of a rich medium,

(ii) use of serum, especially foetal calf serum, in the medium,

(iii) using conditioned medium (a medium in which homologous cells were grown for a period of time),

(iv) use of feeder layers,

(v) addition of hormones like insulin, dexamethasone, etc.,

(vi) providing intermediate metabolites like keto acids, nucleosides, etc.

A feeder layer is a layer of cells, which have been treated to prevent their growth and ultimately cause their death (cells irradiated with X-rays or gamma-rays at 3,000 rads die in 3 weeks); these cells, however, provide the necessary metabolites to enhance the plating efficiency of cells being cloned.

A feeder layer may be established by trypsinising embryo fibroblasts from a primary culture and reseeding the cells at 105 cells/ml density. When the monolayer reaches 50% confluence (50% of the substrate surface is covered by the monolayer) the cells are either treated with mitomycin-C (0.25 μg/ml solution at the rate of 2 μg/106 cells) overnight, or are irradiated with 3,000 rad X-'rays.

After treatment, the cells are incubated for 24 hours in fresh medium, tryspinised and reseeded at 5 x 104cells/ml, and incubated for 24-48 hours. This yields the feeder layer on which cells to be cloned are seeded, incubated and desired colonies isolate.

Feeder layer may be established using homologous cells (cells from the same species), but it is perferable to use heterologous cells for easy detection of accidental cross contamination in the isolated clones.

Cloning is used to

(i) obtain homogeneous cell lines from heterogeneous cell cultures,

(ii) to isolate biochemical mutants and

(iii) cell strains with marker chromosomes, and

(iv) to develop hybridoma clones.

Cloning is generally applied to continuous cell lines, but often their clones become considerably heterogeneous by the time they are sufficiently multiplied for use. The problem with finite cell lines is that of life span; by the time the clone is sufficiently multiplied, the cells may be approaching sensescene.

http://www.molecular-plant-biotechnology.info


Read More......

Wednesday, March 26, 2008

Article : Its all about geometry protein contact surfaces hold key to cures

Your mother always told you to do your geometry homework, and for scientists seeking new treatments for diseases like Parkinson’s and Alzheimer’s, this advice turns out to be right on the mark.

In the atomic-level landscape of proteins, shape determines the all-important function of these molecules of life. For example, when a protein molecule responsible for Parkinson’s binds with the cell membrane, will a new drug candidate interrupt this interaction -- preventing disease progression and protecting the patient" It all depends on the precise geometry and energy of the protein structures.

Researcher Igor Tsigelny and colleagues at the San Diego Supercomputer Center (SDSC) and UC San Diego have developed a new tool known as MAPAS (Membrane-Associated Protein Assessments) which harnesses the power of supercomputers at SDSC and Argonne National Laboratory to study how proteins contact cell membranes. It turns out that this three-dimensional “virtual molecular world” is very good at letting researchers zoom in on key details of this all-important contact process, holding out the promise of new treatments for a wide range of devastating diseases, from Parkinson's and Alzheimer's to kidney disease and cancer.

“It’s extremely important to explore the structural details of the zone where the protein contacts the membrane so that we can understand the molecular mechanisms of disease development,” said Tsigelny. “This knowledge gives crucial guidance in selecting which among many possible compounds are most likely to do well in tests to intervene in such protein-membrane interactions and help treat these diseases.”

The researchers describe the new MAPAS tool in the February 2008 (vol. 5 no. 2) online edition of Nature Methods. In addition to Tsigelny, the other authors, who are all at UCSD, include Yuriy Sharikov, Ross Walker, Jerry Greenberg, Valentina Kouznetsova, Sanjay Nigam, Mark Miller, and Eliezer Masliah.

In studying a protein, the traditional approach is to crystallize it and then illuminate it with X-rays, which yields information about its three-dimensional geometry, or “protein structure.” But this method has great difficulty in identifying the key parts of a protein that will participate in membrane contact.

“That’s why it’s very important to be able to predict these protein contact surfaces theoretically, using a computer program like we’ve developed,” said Tsigelny.

In making its predictions, MAPAS starts with a simple idea from geometry. Because an individual protein molecule is so much smaller than a round cell, the cell membrane looks like a flat surface as the protein approaches it -- just as the spherical earth appears flat to a person walking on it. This approach allows the researchers to more efficiently compute the structural information they are seeking.

The MAPAS tool takes as a starting point a protein’s known three-dimensional shape, and then applies a set of scoring methods based on comprehensive Steered Molecular Dynamics calculations to predict whether this protein structure can form strong contacts with the cell membrane. If so, MAPAS goes on to identify all the flat faces or planes that make up this protein. It is these planar protein surfaces that can attach to the cell membrane, and MAPAS predicts which of these regions are most likely to bind to the membrane, based on specific protein contacts with the lipids or fats that make up the membrane.

The team has validated the performance of MAPAS by confirming that it correctly models a number of membrane-contacting proteins that are already known.

The powerful MAPAS program with its virtual protein world is already providing important benefits in both extending basic scientific understanding of proteins and fighting disease.

“For example, without the MAPAS program we wouldn’t have been able to develop the important new model we found for Parkinson’s disease,” Tsigelny explained. He and his colleagues have already published an important advance in understanding this disease, based on computations using MAPAS. These new insights can in turn open important avenues for developing new treatments.

Added Tsigelny, “We’re also currently using MAPAS to study Alzheimer's disease mechanisms as well as molecular models of the processes involved in kidney disease and some cancers.”

The importance of the work has been recognized by a prestigious Department of Energy (DOE) Innovative and Novel Computational Impact on Theory and Experiment (INCITE) award of 1.2 million processor hours, which will allow the team to run their programs on a supercomputer at Argonne National Laboratory and extend their research on Parkinson’s disease.

The researchers are also working to create a supercomputer-powered system that unites multiple programs, including MAPAS with multiple data sources, to carry out comprehensive studies of the mechanisms in diseases involving membrane-protein connections.

Source : University of California - San Diego

Read More......

Tuesday, March 25, 2008

article : Clon and Research Development

For the cloning of human beings, see human cloning. For other uses, see clone (disambiguation).

Cloning is the process of making an identical copy of something. In biology, it collectively refers to processes used to create copies of DNA fragments (molecular cloning), cells (cell cloning), or organisms. The term also covers when organisms such as bacteria, insects or plants reproduce asexually.

Etymology

The term clone is derived from κλών, the Greek word for "twig, branch", referring to the process whereby a new plant can be created from a twig. In horticulture, the spelling clon was used until the twentieth century; the final e came into use to indicate the vowel is a "long o" instead of a "short o"[citation needed]. Since the term entered the popular lexicon in a more general context, the spelling clone has been used exclusively.

Molecular cloning

Main article: Molecular cloning

Molecular cloning refers to the procedure of isolating a defined DNA sequence and obtaining multiple copies of it in vivo. Cloning is frequently employed to amplify DNA fragments containing genes, but it can be used to amplify any DNA sequence such as promoters, non-coding sequences and randomly fragmented DNA. It is utilised in a wide array of biological experiments and practical applications such as large scale protein production. Occasionally, the term cloning is misleadingly used to refer to the identification of the chromosomal location of a gene associated with a particular phenotype of interest, such as in positional cloning. In practice, localization of the gene to a chromosome or genomic region does not necessarily enable one to isolate or amplify the relevant genomic sequence.

In essence, in order to amplify any DNA sequence in a living organism, that sequence must be linked to an origin of replication, a sequence element capable of directing the propagation of itself and any linked sequence. In practice, however, a number of other features are desired and a variety of specialised cloning vectors exist that allow protein expression, tagging, single stranded RNA and DNA production and a host of other manipulations.

Cloning of any DNA fragment essentially involves four steps: fragmentation, ligation, transfection, and screening/selection. Although these steps are invariable among cloning procedures a number of alternative routes can be selected, these are summarized as a ‘cloning strategy’.

Initially, the DNA of interest needs to be isolated to provide a DNA segment of suitable size. Subsequently, a ligation procedure is used where the amplified fragment is inserted into a vector. The vector (which is frequently circular) is linearised using restriction enzymes, and incubated with the fragment of interest under appropriate conditions with an enzyme called DNA ligase. Following ligation the vector with the insert of interest is transfected into cells. A number of alternative techniques are available, such as chemical sensitivation of cells, electroporation and biolistics. Finally, the transfected cells are cultured. As the aforementioned procedures are of particularly low efficiency, there is a need to identify the cells that have been successfully transfected with the vector construct containing the desired insertion sequence in the required orientation. Modern cloning vectors include selectable antibiotic resistance markers, which allow only cells in which the vector has been transfected, to grow. Additionally, the cloning vectors may contain colour selection markers which provide blue/white screening (α-factor complementation) on X-gal medium. Nevertheless, these selection steps do not absolutely guarantee that the DNA insert is present in the cells obtained. Further investigation of the resulting colonies is required to confirm that cloning was successful. This may be accomplished by means of PCR, restriction fragment analysis and/or DNA sequencing.

Cellular cloning

Cloning cell-line colonies using cloning rings
Cloning cell-line colonies using cloning rings

Cloning a cell means to derive a population of cells from a single cell. In the case of unicellular organisms such as bacteria and yeast, this process is remarkably simple and essentially only requires the inoculation of the appropriate medium. However, in the case of cell cultures from multi-cellular organisms, cell cloning is an arduous task as these cells will not readily grow in standard media.

A useful tissue culture technique used to clone distinct lineages of cell lines involves the use of cloning rings (cylinders). According to this technique, a single-cell suspension of cells which have been exposed to a mutagenic agent or drug used to drive selection is plated at high dilution to create isolated colonies; each arising from a single and potentially clonally distinct cell. At an early growth stage when colonies consist of only a few of cells, sterile polystyrene rings (cloning rings), which have been dipped in grease are placed over an individual colony and a small amount of trypsin is added. Cloned cells are collected from inside the ring and transferred to a new vessel for further growth.

Cloning in stem cell research

Somatic cell nuclear transfer can also be used to create a clonal embryo. The most likely purpose for this is to produce embryos for use in research, particularly stem cell research. This process is also called "research cloning" or "therapeutic cloning." The goal is not to create cloned human beings, but rather to harvest stem cells that can be used to study human development and to potentially treat disease. While a clonal human blastocyst has been created, stem cell lines are yet to be isolated from a clonal source.[1]

Organism cloning

Main article: Asexual reproduction

Organism cloning refers to the procedure of creating a new multicellular organism, genetically identical to another. In essence this form of cloning is an asexual method of reproduction, where fertilization or inter-gamete contact does not take place. Asexual reproduction is a naturally occurring phenomenon in many species, including most plants (see vegetative reproduction) and some insects.

Horticultural

The term clone is used in horticulture to mean all descendants of a single plant, produced by vegetative reproduction or apomixis. Many horticultural plant cultivars are clones, having been derived from a single individual, multiplied by some process other than sexual reproduction. As an example, some European cultivars of grapes represent clones that have been propagated for over two millennia. Other examples are potato and banana. Grafting can be regarded as cloning, since all the shoots and branches coming from the graft are genetically a clone of a single individual, but this particular kind of cloning has not come under ethical scrutiny and is generally treated as an entirely different kind of operation. Grafting, and hence cloning, of apples, pears, peaches, almonds, and persimmons can be traced back at least to 5000BC, as performed by the Chinese diplomat Feng Li[2].

Many trees, shrubs, vines, ferns and other herbaceous perennials form clonal colonies. Parts of a large clonal colony often become detached from the parent, termed fragmentation, to form separate individuals. Some plants also form seeds asexually, termed apomixis, e.g. dandelion.

Parthenogenesis

Clonal derivation exists in nature in some animal species and is referred to as parthenogenesis. An example is the "Little Fire Ant" (Wasmannia auropunctata), which is native to Central and South America but has spread throughout many tropical environments.

Reproductive cloning

Reproductive cloning uses "somatic cell nuclear transfer" (SCNT) to create animals that are genetically identical. This process entails the transfer of a nucleus from a donor adult cell (somatic cell) to an egg which has no nucleus. If the egg begins to divide normally it is transferred into the uterus of the surrogate mother.

Such clones are not strictly identical since the somatic cells may contain mutations in their nuclear DNA. Additionally, the mitochondria in the cytoplasm also contains DNA and during SCNT this DNA is wholly from the donor egg, thus the mitochondrial genome is not the same as that of the nucleus donor cell from which it was produced. This may have important implications for cross-species nuclear transfer in which nuclear-mitochondrial incompatibilities may lead to death.

Dolly the Sheep

Main article: Dolly the Sheep

Dolly (1996-07-052003-02-14), a Finn Dorsett ewe, was the first mammal to have been successfully cloned from an adult cell, though the first actual thing to be cloned, was a tadpole in 1952. She was cloned at the Roslin Institute in Scotland and lived there until her death when she was six. On 2003-04-09 her stuffed remains were placed at Edinburgh's Royal Museum, part of the National Museums of Scotland.

Dolly was publicly significant because the effort showed that the genetic material from a specific adult cell, programmed to express only a distinct subset of its genes, could be reprogrammed to grow an entire new organism. Before this demonstration, there was no proof for the widely spread hypothesis that differentiated animal cells can give rise to entire new organisms.

Cloning Dolly the sheep had a low success rate per fertilized egg; she was born after 277 eggs were used to create 29 embryos, which only produced three lambs at birth, only one of which lived. Seventy calves have been created from 9,000 attempts and one third of them died young; Prometea took 328 attempts. Notably, although the first clones were frogs, no adult cloned frog has yet been produced from a somatic adult nucleus donor cell.

There were early claims that Dolly the Sheep had pathologies resembling accelerated aging. Scientists speculated that Dolly's death in 2003 was related to the shortening of telomeres, DNA-protein complexes that protect the end of linear chromosomes. However, other researchers, including Ian Wilmut who led the team that successfully cloned Dolly, argue that Dolly's early death due to respiratory infection was unrelated to deficiencies with the cloning process.


Species cloned

The modern cloning techniques involving nuclear transfer have been successfully performed on several species. Landmark experiments in chronological order:

  • Tadpole: (1952) Many scientists questioned whether cloning had actually occurred and unpublished experiments by other labs were not able to reproduce the reported results.
  • Carp: (1963) In China, embryologist Tong Dizhou cloned a fish. He published the findings in an obscure Chinese science journal which was never translated into English.[3]
  • Mice: (1986) was the first successfully cloned mammal; Soviet scientists Chaylakhyan, Veprencev, Sviridova, Nikitin had mice "Masha" cloned. Research was published in the magazine "Biofizika" volume ХХХII, issue 5 of 1987.[4]
  • Sheep: (1996) From early embryonic cells by Steen Willadsen. Megan and Morag cloned from differentiated embryonic cells in June 1995 and Dolly the sheep from a somatic cell in 1997.
  • Human: (November 1998) hybrid embryo created from leg cells and a cleaned cow egg - not allowed to implant in a womb, nor develop, nor be born due to ethical issues.
  • Rhesus Monkey: Tetra (female, January 2000) from embryo splitting
  • Cattle: Alpha and Beta (males, 2001) and (2005) Brazil[5]
  • Cat: CopyCat "CC" (female, late 2001), Little Nicky, 2004, was the first cat cloned for commercial reasons
  • Mule: Idaho Gem, a john mule born 4 May 2003, was the first horse-family clone.
  • Horse: Prometea, a Haflinger female born 28 May 2003, was the first horse clone.

For a complete list see: List of animals that have been cloned.

Human cloning

Main article: Human cloning

Human cloning is the creation of a genetically identical copy of an existing or previously existing human. The term is generally used to refer to artificial human cloning; human clones in the form of identical twins are commonplace, with their cloning occurring during the natural process of reproduction. There are two commonly discussed types of human cloning: therapeutic cloning and reproductive cloning. Therapeutic cloning involves cloning cells from an adult for use in medicine and is an active area of research: while reproductive cloning would involve making cloned human beings. Such reproductive cloning has not been performed and is illegal in many countries. A third type of cloning called replacement cloning is a theoretical possibility, and would be a combination of therapeutic and reproductive cloning. Replacement cloning would entail the replacement of an extensively damaged, failed, or failing body through cloning followed by whole or partial brain transplant.

The various forms of human cloning are controversial.[6] There have been numerous demands for all progress in the human cloning field to be halted. Some people and groups oppose therapeutic cloning, but most scientific, governmental and religious organizations oppose reproductive cloning. The American Association for the Advancement of Science (AAAS) and other scientific organizations have made public statements suggesting that human reproductive cloning be banned until safety issues are resolved [7]. Serious ethical concerns have been raised by the idea that it might be possible in the future to harvest organs from clones. Some people have considered the idea of growing organs separately from a human organism - in doing this, a new organ supply could be established without the moral implications of harvesting them from humans. Research is also being done on the idea of growing organs that are biologically acceptable to the human body inside of other organisms, such as pigs or cows, then transplanting them to humans, a form of xenotransplantation.

The first human hybrid human clone was created in November 1998, by American Cell Technologies.[8]. It was created from a man's leg cell, and a cow's egg whose DNA was removed. It was destroyed after 12 days. Since a normal embryo implants at 14 days, Dr Robert Lanza, ACT's director of tissue engineering, told the Daily Mail newspaper that the embryo could not be seen as a person before 14 days. While making an embryo, which may have resulted in complete human had it been allowed to come to term, according to ACT: "[ACT's] aim was 'therapeutic cloning' not 'reproductive cloning'"

On January, 2008, Wood and Andrew French, Stemagen's chief scientific officer in California, announced that they successfully created the first 5 mature human embryos using DNA from adult skin cells, aiming to provide a source of viable embryonic stem cells. Dr. Samuel Wood and a colleague donated skin cells, and DNA from those cells was transferred to human eggs. It is not clear if the embryos produced would have been capable of further development, but Dr. Wood stated that if that were possible, using the technology for reproductive cloning would be both unethical and illegal. The 5 cloned embryos, created in Stemagen Corporation lab, in La Jolla, were destroyed.[9]

Ethical issues of cloning

Main article: Ethics of cloning

Although the practice of cloning organisms has been widespread for several thousands of years in the form of horticultural cloning, the recent technological advancements that have allowed for cloning of animals (and potentially humans) have been highly controversial. Some believe[citation needed] it is unethical to use a human clone to save the life of another. Others have countered that people who exist today and have interpersonal relationships and personal histories should take precedence over never-conscious life at any stage of developmental maturity. The Catholic Church and various traditionalist religious groups oppose all forms of cloning, on the grounds that life begins at conception. Conversely, Judaism does not equate life with conception and, though some question the wisdom of cloning, Orthodox rabbis generally find no firm reason in Jewish law and ethics to object to cloning.[10] From the standpoint of classical liberalism, concerns also exist regarding the protection of the identity of the individual and the right to protect one's genetic identity.

Gregory Stock is a scientist and outspoken critic against restrictions on cloning research.[11]

The social implications of an artificial human production scheme were famously explored in Aldous Huxley's novel Brave New World.

According to the US Food and Drug Administration, food coming from cloned animals is safe to eat. In addition the FDA stated that cloned food does not require special labeling. Both meat and milk from cloned animals such as swine, goats and cattle has no differencies from the conventionally bred animals.

Joseph Mendelson, legal director of the Center for Food Safety, said that cloned food still should be labeled due to the fact that safety and ethical issues of it remain questionable.

Carol Tucker Foreman, director of food policy at the Consumer Federation of America, stated that FDA does not consider the fact that the results of some studies revealed that cloned animals have increased rates of mortality and deformity at birth.

FDA specialists mentioned that when the cloned animals are aged from 6 to 18 months, they are almost similar to conventionally bred animals. The food receives a certain label only in cases when its features are modified by the way it is produced. [12]

Cloning extinct and endangered species

Cloning, or more precisely, the reconstruction of functional DNA from extinct species has, for decades, been a dream of some scientists. The possible implications of this were dramatized in the best-selling novel by Michael Crichton and high budget Hollywood thriller Jurassic Park. In real life, one of the most anticipated targets for cloning was once the Woolly Mammoth, but attempts to extract DNA from frozen mammoths have been unsuccessful, though a joint Russo-Japanese team is currently working toward this goal.[13]

In 2001, a cow named Bessie gave birth to a cloned Asian gaur, an endangered species, but the calf died after two days. In 2003, a banteng was successfully cloned, followed by three African wildcats from a thawed frozen embryo. These successes provided hope that similar techniques (using surrogate mothers of another species) might be used to clone extinct species. Anticipating this possibility, tissue samples from the last bucardo (Pyrenean Ibex) were frozen immediately after it died. Researchers are also considering cloning endangered species such as the giant panda, ocelot, and cheetah. The "Frozen Zoo" at the San Diego Zoo now stores frozen tissue from the world's rarest and most endangered species.[14][15]

In 2002, geneticists at the Australian Museum announced that they had replicated DNA of the Thylacine (Tasmanian Tiger), extinct about 65 years previous, using polymerase chain reaction.[16] However, on 2005-02-15 the museum announced that it was stopping the project after tests showed the specimens' DNA had been too badly degraded by the (ethanol) preservative. Most recently, on 2005-05-15, it was announced that the Thylacine project would be revived, with new participation from researchers in New South Wales and Victoria.

One of the continuing obstacles in the attempt to clone extinct species is the need for nearly perfect DNA. Cloning from a single specimen could not create a viable breeding population in sexually reproducing animals. Furthermore, even if males and females were to be cloned, the question would remain open whether they would be viable at all in the absence of parents that could teach or show them their natural behavior. Essentially, if cloning an extinct species were successful — it must be considered that cloning is still an experimental technology that succeeds only by chance. It is far more likely than not that any resulting animals, even if they were healthy, would be little more than curious or museum pieces.

Cloning endangered species is a highly ideological issue. Many conservation biologists and environmentalists vehemently oppose cloning endangered species — not because they think it won't work but because they think it may deter donations to help preserve natural habitat and wild animal populations. The "rule-of-thumb" in animal conservation is that, if it is still feasible to conserve habitat and viable wild populations, breeding in captivity should not be undertaken in isolation.

In a 2006 review, David Ehrenfeld concluded that cloning in animal conservation is an experimental technology that, at its state in 2006, could not be expected to work except by pure chance and utterly failed a cost-benefit analysis.[17] Furthermore, he said, it is likely to siphon funds from established and working projects and does not address any of the issues underlying animal extinction (such as habitat destruction, hunting or other overexploitation, and an impoverished gene pool). While cloning technologies are well-established and used on a regular basis in plant conservation, care must be taken to ensure genetic diversity. He concluded:

Vertebrate cloning poses little risk to the environment, but it can consume scarce conservation resources, and its chances of success in preserving species seem poor. To date, the conservation benefits of transgenics and vertebrate cloning remain entirely theoretical, but many of the risks are known and documented. Conservation biologists should devote their research and energies to the established methods of conservation, none of which require transgenics or vertebrate cloning.[17]

References

  1. ^ Gil, Gideon. "California biotech says it cloned a human embryo, but no stem cells produced", Boston Globe, 2008-01-17.
  2. ^ [ http://www.hort.purdue.edu/newcrop/maia/history.html Great Moments in Apple History ]
  3. ^ BLOODLINES. Timeline
  4. ^ whoiswho.ru
  5. ^ Wikinews: Endangered cow cloned in Brazil, 22 May 2005
  6. ^ Pence, Gregory E. (1998). Who’s Afraid of Human Cloning?. Rowman & Littlefield. paperback ISBN 0-8476-8782-1 and hardcover ISBN 0-8476-8781-3.
  7. ^ AAAS Statement on Human Cloning.
  8. ^ BBC News | SCI/TECH | Details of hybrid clone revealed
  9. ^ Mature Human Embryos Created From Adult Skin Cells Washingtonpost.com
  10. ^ Michael Brody. Avraham Steinberg.
  11. ^ New Page 0
  12. ^ Meat of Cloned Food is Safe to Eat, FDA Says
  13. ^ "Scientists 'to clone mammoth'", BBC News, 2003-08-18.
  14. ^ Heidi B. Perlman. "Scientists Close on Extinct Cloning", Associated Press, 2000-10-08.
  15. ^ Pence, Gregory E. (2005). Cloning After Dolly: Who's Still Afraid?. Rowman & Littlefield. ISBN 0-7425-3408-1.
  16. ^ Holloway, Grant. "Cloning to revive extinct species", CNN.com, 2002-05-28.
  17. ^ a b Ehrenfeld, David (2006). "Transgenics and Vertebrate Cloning as Tools for Species Conservation". Conservation Biology 20 (3): 723-732. doi:10.1111/j.1523-1739.2006.00399.x. PMID 16909565.

External links and references


Read More......

Information : Required Cloning Articles for Background Information


Each group is responsible for knowing the material contained in these articles. All members need to read the concluding article, Got regulations. May need more. Your group should divide up the first eight articles, summarize and share the information with others in your group.

Cloning Articles for Your Research

Now that you have acquired background information on cloning, choose from the following list of resources to expand your research. Be sure to cite all sources you use. Articles are categorized according to source or topic.

New Scientist Magazine Cloning Special Report

Other Sources

Challenging Scientific Article Whether Laws on Cloning Will Work

Resources

Source : http://www.west.asu.edu/

Read More......

Monday, March 24, 2008

article : Its all about geometry protein contact surfaces hold key to cures

Your mother always told you to do your geometry homework, and for scientists seeking new treatments for diseases like Parkinson’s and Alzheimer’s, this advice turns out to be right on the mark.


In the atomic-level landscape of proteins, shape determines the all-important function of these molecules of life. For example, when a protein molecule responsible for Parkinson’s binds with the cell membrane, will a new drug candidate interrupt this interaction -- preventing disease progression and protecting the patient" It all depends on the precise geometry and energy of the protein structures.


Researcher Igor Tsigelny and colleagues at the San Diego Supercomputer Center (SDSC) and UC San Diego have developed a new tool known as MAPAS (Membrane-Associated Protein Assessments) which harnesses the power of supercomputers at SDSC and Argonne National Laboratory to study how proteins contact cell membranes. It turns out that this three-dimensional “virtual molecular world” is very good at letting researchers zoom in on key details of this all-important contact process, holding out the promise of new treatments for a wide range of devastating diseases, from Parkinson's and Alzheimer's to kidney disease and cancer.


“It’s extremely important to explore the structural details of the zone where the protein contacts the membrane so that we can understand the molecular mechanisms of disease development,” said Tsigelny. “This knowledge gives crucial guidance in selecting which among many possible compounds are most likely to do well in tests to intervene in such protein-membrane interactions and help treat these diseases.”


The researchers describe the new MAPAS tool in the February 2008 (vol. 5 no. 2) online edition of Nature Methods. In addition to Tsigelny, the other authors, who are all at UCSD, include Yuriy Sharikov, Ross Walker, Jerry Greenberg, Valentina Kouznetsova, Sanjay Nigam, Mark Miller, and Eliezer Masliah.

In studying a protein, the traditional approach is to crystallize it and then illuminate it with X-rays, which yields information about its three-dimensional geometry, or “protein structure.” But this method has great difficulty in identifying the key parts of a protein that will participate in membrane contact.

“That’s why it’s very important to be able to predict these protein contact surfaces theoretically, using a computer program like we’ve developed,” said Tsigelny.
In making its predictions, MAPAS starts with a simple idea from geometry. Because an individual protein molecule is so much smaller than a round cell, the cell membrane looks like a flat surface as the protein approaches it -- just as the spherical earth appears flat to a person walking on it. This approach allows the researchers to more efficiently compute the structural information they are seeking.

The MAPAS tool takes as a starting point a protein’s known three-dimensional shape, and then applies a set of scoring methods based on comprehensive Steered Molecular Dynamics calculations to predict whether this protein structure can form strong contacts with the cell membrane. If so, MAPAS goes on to identify all the flat faces or planes that make up this protein. It is these planar protein surfaces that can attach to the cell membrane, and MAPAS predicts which of these regions are most likely to bind to the membrane, based on specific protein contacts with the lipids or fats that make up the membrane.

The team has validated the performance of MAPAS by confirming that it correctly models a number of membrane-contacting proteins that are already known.
The powerful MAPAS program with its virtual protein world is already providing important benefits in both extending basic scientific understanding of proteins and fighting disease.
“For example, without the MAPAS program we wouldn’t have been able to develop the important new model we found for Parkinson’s disease,” Tsigelny explained. He and his colleagues have already published an important advance in understanding this disease, based on computations using MAPAS. These new insights can in turn open important avenues for developing new treatments.

Added Tsigelny, “We’re also currently using MAPAS to study Alzheimer's disease mechanisms as well as molecular models of the processes involved in kidney disease and some cancers.”
The importance of the work has been recognized by a prestigious Department of Energy (DOE) Innovative and Novel Computational Impact on Theory and Experiment (INCITE) award of 1.2 million processor hours, which will allow the team to run their programs on a supercomputer at Argonne National Laboratory and extend their research on Parkinson’s disease.
The researchers are also working to create a supercomputer-powered system that unites multiple programs, including MAPAS with multiple data sources, to carry out comprehensive studies of the mechanisms in diseases involving membrane-protein connections.
Source : University of California - San Diego

Read More......

Tuesday, March 4, 2008

article : Parts of Biochemistry

Friedrich Wöhler

Originally, it was generally believed that life was not subject to the laws of science the way non-life was. It was thought that only living beings could produce the molecules of life (from other, previously existing biomolecules). Then, in 1828, Friedrich Wöhler published a paper on the synthesis of urea, proving that organic compounds can be created artificially.[2][3]

The dawn of biochemistry may have been the discovery of the first enzyme, diastase (today called amylase), in 1833 by Anselme Payen. Eduard Buchner contributed the first demonstration of a complex biochemical process outside of a cell in 1896: alcoholic fermentation in cell extracts of yeast. Although the term “biochemistry” seems to have been first used in 1882, it is generally accepted that the formal coinage of biochemistry occurred in 1903 by Carl Neuberg, a German chemist. Previously, this area would have been referred to as physiological chemistry. Since then, biochemistry has advanced, especially since the mid-20th century, with the development of new techniques such as chromatography, X-ray diffraction, NMR spectroscopy, radioisotopic labeling, electron microscopy and molecular dynamics simulations. These techniques allowed for the discovery and detailed analysis of many molecules and metabolic pathways of the cell, such as glycolysis and the Krebs cycle (citric acid cycle).

Another significant historic event in biochemistry is the discovery of the gene and the its role in transfer of information in the cell. This part of biochemistry is often called molecular biology. In the 1950's, James D. Watson, Francis Crick, Rosalind Franklin, and Maurice Wilkins were instrumental in solving DNA structure and suggesting its relationship with genetic transfer of information. In 1958, George Beadle and Edward Tatum received the Nobel Prize for work in fungi showing that one gene produces one enzyme. In 1988, Colin Pitchfork was the first person convicted of murder with DNA evidence, which led to growth of forensic science. More recently, Andrew Z. Fire and Craig C. Mello received the 2006 Nobel Prize for discovering the role of RNA interference (RNAi), in the silencing of gene expression.

Today, there are three main types of biochemistry as established by Michael E. Sugar. Plant biochemistry involves the study of the biochemistry of autotrophic organisms such as photosynthesis and other plant specific biochemical processes. General biochemistry encompasses both plant and animal biochemistry. Human/medical/medicinal biochemistry focuses on the biochemistry of humans and medical illnesses.

Carbohydrates
Main article: Carbohydrate
The function of carbohydrates includes energy storage and providing structure. Sugars are carbohydrates, but not all carbohydrates are sugars. There are more carbohydrates on Earth than any other known type of biomolecule.

Monosaccharides

Glucose
The simplest type of carbohydrate is a monosaccharide, which among other properties contains carbon, hydrogen, and oxygen, mostly in a ratio of 1:2:1 (generalized formula CnH2nOn, where n is at least 3). Glucose, one of the most important carbohydrates, is an example of a monosaccharide. So is fructose, the sugar that gives fruits their sweet taste. Some carbohydrates (especially after condensation to oligo- and polysaccharides) contain less carbon relative to H and O, which still are present in 2:1 (H:O) ratio. Monosaccharides can be grouped into aldoses (having an aldehyde group at the end of the chain, e. g. glucose) and ketoses (having a keto group in their chain; e. g. fructose). Both aldoses and ketoses occur in an equilibrium between the open-chain forms and (starting with chain lengths of C4) cyclic forms. These are generated by bond formation between one of the hydroxyl groups of the sugar chain with the carbon of the aldehyde or keto group to form a hemiacetal bond. This leads to saturated five-membered (in furanoses) or six-membered (in pyranoses) heterocyclic rings containing one O as heteroatom.

Disaccharides

Sucrose: ordinary table sugar and probably the most familiar carbohydrate.
Two monosaccharides can be joined together using dehydration synthesis, in which a hydrogen atom is removed from the end of one molecule and a hydroxyl group (—OH) is removed from the other; the remaining residues are then attached at the sites from which the atoms were removed. The H—OH or H2O is then released as a molecule of water, hence the term dehydration. The new molecule, consisting of two monosaccharides, is called a disaccharide and is conjoined together by a glycosidic or ether bond. The reverse reaction can also occur, using a molecule of water to split up a disaccharide and break the glycosidic bond; this is termed hydrolysis. The most well-known disaccharide is sucrose, ordinary sugar (in scientific contexts, called table sugar or cane sugar to differentiate it from other sugars). Sucrose consists of a glucose molecule and a fructose molecule joined together. Another important disaccharide is lactose, consisting of a glucose molecule and a galactose molecule. As most humans age, the production of lactase, the enzyme that hydrolyzes lactose back into glucose and galactose, typically decreases. This results in lactase deficiency, also called lactose intolerance.

Sugar polymers are characterised by having reducing or non-reducing ends. A reducing end of a carbohydrate is a carbon atom which can be in equilibrium with the open-chain aldehyde or keto form. If the joining of monomers takes place at such a carbon atom, the free hydroxy group of the pyranose or furanose form is exchanged with an OH-side chain of another sugar, yielding a full acetal. This prevents opening of the chain to the aldehyde or keto form and renders the modified residue non-reducing. Lactose contains a reducing end at its glucose moiety, whereas the galactose moiety form a full acetal with the C4-OH group of glucose. Saccharose does not have a reducing end because of full acetal formation between the aldehyde carbon of glucose (C1) and the keto carbon of fructose (C2).

Oligosaccharides and polysaccharides

Cellulose as polymer of β-D-glucose
When a few (around three to six) monosaccharides are joined together, it is called an oligosaccharide (oligo- meaning "few"). These molecules tend to be used as markers and signals, as well as having some other uses.

Many monosaccharides joined together make a polysaccharide. They can be joined together in one long linear chain, or they may be branched. Two of the most common polysaccharides are cellulose and glycogen, both consisting of repeating glucose monomers.
Cellulose is made by plants and is an important structural component of their cell walls. Humans can neither manufacture nor digest it.
Glycogen, on the other hand, is an animal carbohydrate; humans and other animals use it as a form of energy storage.

Use of carbohydrates as an energy source
See also carbohydrate metabolism
Glucose is the major energy source in most life forms. For instance, polysaccharides are broken down into their monomers (glycogen phosphorylase removes glucose residues from glycogen). Disaccharides like lactose or sucrose are cleaved into their two component monosaccharides.

Glycolysis (anaerobic)
Glucose is mainly metabolized by a very important and ancient ten-step pathway called glycolysis, the net result of which is to break down one molecule of glucose into two molecules of pyruvate; this also produces a net two molecules of ATP, the energy currency of cells, along with two reducing equivalents in the form of converting NAD+ to NADH. This does not require oxygen; if no oxygen is available (or the cell cannot use oxygen), the NAD is restored by converting the pyruvate to lactate (lactic acid) (e. g. in humans) or to ethanol plus carbon dioxide (e. g. in yeast). Other monosaccharides like galactose and fructose can be converted into intermediates of the glycolytic pathway.

Aerobic
In aerobic cells with sufficient oxygen, like most human cells, the pyruvate is further metabolized. It is irreversibly converted to acetyl-CoA, giving off one carbon atom as the waste product carbon dioxide, generating another reducing equivalent as NADH. The two molecules acetyl-CoA (from one molecule of glucose) then enter the citric acid cycle, producing two more molecules of ATP, six more NADH molecules and two reduced (ubi)quinones (via FADH2 as enzyme-bound cofactor), and releasing the remaining carbon atoms as carbon dioxide. The produced NADH and quinol molecules then feed into the enzyme complexes of the respiratory chain, an electron transport system transferring the electrons ultimately to oxygen and conserving the released energy in the form of a proton gradient over a membrane (inner mitochondrial membrane in eukaryotes). Thereby, oxygen is reduced to water and the original electron acceptors NAD+ and quinone are regenerated. This is why humans breathe in oxygen and breathe out carbon dioxide. The energy released from transferring the electrons from high-energy states in NADH and quinol is conserved first as proton gradient and converted to ATP via ATP synthase. This generates an additional 28 molecules of ATP (24 from the 8 NADH + 4 from the 2 quinols), totaling to 32 molecules of ATP conserved per degraded glucose (two from glycolysis + two from the citrate cycle). It is clear that using oxygen to completely oxidize glucose provides an organism with far more energy than any oxygen-independent metabolic feature, and this is thought to be the reason why complex life appeared only after Earth's atmosphere accumulated large amounts of oxygen.

Gluconeogenesis
Main article: Gluconeogenesis
In vertebrates, vigorously contracting skeletal muscles (during weightlifting or sprinting, for example) do not receive enough oxygen to meet the energy demand, and so they shift to anaerobic metabolism, converting glucose to lactate. The liver regenerates the glucose, using a process called gluconeogenesis. This process is not quite the opposite of glycolysis, and actually requires three times the amount of energy gained from glycolysis (six molecules of ATP are used, compared to the two gained in glycolysis). Analogous to the above reactions, the glucose produced can then undergo glycolysis in tissues that need energy, be stored as glycogen (or starch in plants), or be converted to other monosaccharides or joined into di- or oligosaccharides.

Proteins
Main article: Protein

A schematic of hemoglobin. The red and blue ribbons represent the protein globin; the green structures are the heme groups.
Like carbohydrates, some proteins perform largely structural roles. For instance, movements of the proteins actin and myosin ultimately are responsible for the contraction of skeletal muscle. One property many proteins have is that they specifically bind to a certain molecule or class of molecules—they may be extremely selective in what they bind. Antibodies are an example of proteins that attach to one specific type of molecule. In fact, the enzyme-linked immunosorbent assay (ELISA), which uses antibodies, is currently one of the most sensitive tests modern medicine uses to detect various biomolecules. Probably the most important proteins, however, are the enzymes. These amazing molecules recognize specific reactant molecules called substrates; they then catalyze the reaction between them. By lowering the activation energy, the enzyme speeds up that reaction by a rate of 1011 or more: a reaction that would normally take over 3,000 years to complete spontaneously might take less than a second with an enzyme. The enzyme itself is not used up in the process, and is free to catalyze the same reaction with a new set of substrates. Using various modifiers, the activity of the enzyme can be regulated, enabling control of the biochemistry of the cell as a whole.

In essence, proteins are chains of amino acids. An amino acid consists of a carbon atom bound to four groups. One is an amino group, —NH2, and one is a carboxylic acid group, —COOH (although these exist as —NH3+ and —COO− under physiologic conditions). The third is a simple hydrogen atom. The fourth is commonly denoted "—R" and is different for each amino acid. There are twenty standard amino acids. Some of these have functions by themselves or in a modified form; for instance, glutamate functions as an important neurotransmitter.

Generic amino acids (1) in neutral form, (2) as they exist physiologically, and (3) joined together as a dipeptide.
Amino acids can be joined together via a peptide bond. In this dehydration synthesis, a water molecule is removed and the peptide bond connects the nitrogen of one amino acid's amino group to the carbon of the other's carboxylic acid group. The resulting molecule is called a dipeptide, and short stretches of amino acids (usually, fewer than around thirty) are called peptides or polypeptides. Longer stretches merit the title proteins. As an example, the important blood serum protein albumin contains 585 amino acid residues.
The structure of proteins is traditionally described in a hierarchy of four levels. The primary structure of a protein simply consists of its linear sequence of amino acids; for instance, "alanine-glycine-tryptophan-serine-glutamate-asparagine-glycine-lysine-…". Secondary structure is concerned with local morphology. Some combinations of amino acids will tend to curl up in a coil called an α-helix or into a sheet called a β-sheet; some α-helixes can be seen in the hemoglobin schematic above. Tertiary structure is the entire three-dimensional shape of the protein. This shape is determined by the sequence of amino acids. In fact, a single change can change the entire structure. The alpha chain of hemoglobin contains 146 amino acid residues; substitution of the glutamate residue at position 6 with a valine residue changes the behavior of hemoglobin so much that it results in sickle-cell disease. Finally quaternary structure is concerned with the structure of a protein with multiple peptide subunits, like hemoglobin with its four subunits. Not all proteins have more than one subunit.

Ingested proteins are usually broken up into single amino acids or dipeptides in the small intestine, and then absorbed. They can then be joined together to make new proteins. Intermediate products of glycolysis, the citric acid cycle, and the pentose phosphate pathway can be used to make all twenty amino acids, and most bacteria and plants possess all the necessary enzymes to synthesize them. Humans and other mammals, however, can only synthesize half of them. They cannot synthesize isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine. These are the essential amino acids, since it is essential to ingest them. Mammals do possess the enzymes to synthesize alanine, asparagine, aspartate, cysteine, glutamate, glutamine, glycine, proline, serine, and tyrosine, the nonessential amino acids. While they can synthesize arginine and histidine, they cannot produce it in sufficient amounts for young, growing animals, and so these are often considered essential amino acids.
If the amino group is removed from an amino acid, it leaves behind a carbon skeleton called an α-keto acid. Enzymes called transaminases can easily transfer the amino group from one amino acid (making it an α-keto acid) to another α-keto acid (making it an amino acid). This is important in the biosynthesis of amino acids, as for many of the pathways, intermediates from other biochemical pathways are converted to the α-keto acid skeleton, and then an amino group is added, often via transamination. The amino acids may then be linked together to make a protein.

A similar process is used to break down proteins. It is first hydrolyzed into its component amino acids. Free ammonia (NH3), existing as the ammonium ion (NH4+) in blood, is toxic to life forms. A suitable method for excreting it must therefore exist. Different strategies have evolved in different animals, depending on the animals' needs. Unicellular organisms, of course, simply release the ammonia into the environment. Similarly, bony fish can release the ammonia into the water where it is quickly diluted. In general, mammals convert the ammonia into urea, via the urea cycle.

Lipids
Main article: Lipid
The term lipid comprises a diverse range of molecules and to some extent is a catchall for relatively water-insoluble or nonpolar compounds of biological origin, including waxes, fatty acids, fatty-acid derived phospholipids, sphingolipids, glycolipids and terpenoids (eg. retinoids and steroids). Some lipids are linear aliphatic molecules, while others have ring structures. Some are aromatic, while others are not. Some are flexible, while others are rigid.
Most lipids have some polar character in addition to being largely nonpolar. Generally, the bulk of their structure is nonpolar or hydrophobic ("water-fearing"), meaning that it does not interact well with polar solvents like water. Another part of their structure is polar or hydrophilic ("water-loving") and will tend to associate with polar solvents like water. This makes them amphiphilic molecules (having both hydrophobic and hydrophilic portions). In the case of cholesterol, the polar group is a mere -OH (hydroxyl or alcohol). In the case of phospholipids, the polar groups are considerably larger and more polar, as described below.
Lipids are an integral part of our daily diet. Most oils and milk products that we use for cooking and eating like butter, cheese, ghee etc, are comprised of fats. Vegetable oils are rich in various polyunsaturated fatty acids (PUFA). Lipid-containing foods undergo digestion within the body and are broken into fatty acids and glycerol, which are the final degradation products of fats and lipids.

Nucleic acids
Main article: Nucleic acid
A nucleic acid is a complex, high-molecular-weight biochemical macromolecule composed of nucleotide chains that convey genetic information. The most common nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Nucleic acids are found in all living cells and viruses.
Nucleic acid, so called because of its prevalence in cellular nuclei, is the generic name of the family of biopolymers. The monomers are called nucleotides, and each consists of three components: a nitrogenous heterocyclic base (either a purine or a pyrimidine), a pentose sugar, and a phosphate group. Different nucleic acid types differ in the specific sugar found in their chain (e.g. DNA or deoxyribonucleic acid contains 2-deoxyriboses). Also, the nitrogenous bases possible in the two nucleic acids are different: adenine, cytosine, and guanine occur in both RNA and DNA, while thymine occurs only in DNA and uracil occurs in RNA.

Relationship to other "molecular-scale" biological sciences

Schematic relationship between biochemistry, genetics and molecular biology
Researchers in biochemistry use specific techniques native to biochemistry, but increasingly combine these with techniques and ideas from genetics, molecular biology and biophysics. There has never been a hard-line between these disciplines in terms of content and technique, but members of each discipline have in the past been very territorial; today the terms molecular biology and biochemistry are nearly interchangeable. The following figure is a schematic that depicts one possible view of the relationship between the fields:

Biochemistry is the study of the chemical substances and vital processes occurring in living organisms. Biochemists focus heavily on the role, function, and structure of biomolecules. The study of the chemistry behind biological processes and the synthesis of biologically active molecules are examples of biochemistry.

Genetics is the study of the effect of genetic differences on organisms. Often this can be inferred by the absence of a normal component (e.g. one gene). The study of "mutants" – organisms which lack one or more functional components with respect to the so-called "wild type" or normal phenotype. Genetic interactions (epistasis) can often confound simple interpretations of such "knock-out" studies.

Molecular biology is the study of molecular underpinnings of the process of replication, transcription and translation of the genetic material. The central dogma of molecular biology where genetic material is transcribed into RNA and then translated into protein, despite being an oversimplified picture of molecular biology, still provides a good starting point for understanding the field. This picture, however, is undergoing revision in light of emerging novel roles for RNA.
Chemical Biology seeks to develop new tools based on small molecules that allow minimal perturbation of biological systems while providing detailed information about their function. Further, chemical biology employs biological systems to create non-natural hybrids between biomolecules and synthetic devices (for example emptied viral capsids that can deliver gene therapy or drug molecules).

References

This article is missing citations or needs footnotes.
Using inline citations helps guard against copyright violations and factual inaccuracies. (July 2007)
^ See: Chemistry (etymology)
^ Wöhler, F. (1828). "Ueber künstliche Bildung des Harnstoffs.". Ann. Phys. Chem. 12: 253-256.
^ Kauffman, G. B. and Chooljian, S.H. (2001). "Friedrich Wöhler (1800–1882), on the Bicentennial of His Birth". The Chemical Educator 6 (2): 121-133. doi:10.1007/s00897010444a.

[edit] Further reading
Hunter, Graeme K. (2000). Vital Forces: The Discovery of the Molecular Basis of Life. San Diego: Academic Press. ISBN 0-12-361810-X.
Proceedings of National academy of Science of the United States of America, ISSN: 1091-6490 (electronic)






Read More......

Search by Google

Custom Search
 

Search Engine Optimization - AddMe

Enter your email address:

Delivered by FeedBurner